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Abstract
Identification of facial dysmorphology is essential for the diagnosis of fetal alcohol syndrome 
(FAS); however, most children with fetal alcohol spectrum disorders (FASD) do not meet the 
dysmorphology criterion. Additional objective indicators are needed to help identify the broader 
spectrum of children affected by prenatal alcohol exposure. Computed tomography (CT) was used 
in a sheep model of prenatal binge alcohol exposure to test the hypothesis that quantitative 
measures of craniofacial bone volumes and linear distances could identify alcohol-exposed lambs. 
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Pregnant sheep were randomly assigned to four groups: heavy binge alcohol, 2.5 g/kg/day (HBA); 
binge alcohol, 1.75 g/kg/day (BA); saline control (SC); and normal control (NC). Intravenous 
alcohol (BA; HBA) or saline (SC) infusions were given three consecutive days per week from 
gestation day 4–41, and a CT scan was performed on postnatal day 182. The volumes of eight 
skull bones, cranial circumference, and 19 linear measures of the face and skull were compared 
among treatment groups. Lambs from both alcohol groups showed significant reduction in seven 
of the eight skull bones and total skull bone volume, as well as cranial circumference. Alcohol 
exposure also decreased four of the 19 craniofacial measures. Discriminant analysis showed that 
alcohol-exposed and control lambs could be classified with high accuracy based on total skull 
bone volume, frontal, parietal, or mandibular bone volumes, cranial circumference, or interorbital 
distance. Total skull volume was significantly more sensitive than cranial circumference in 
identifying the alcohol-exposed lambs when alcohol-exposed lambs were classified using the 
typical FAS diagnostic cutoff of ≤10th percentile. This first demonstration of the usefulness of 
CT-derived craniofacial measures in a sheep model of FASD following binge-like alcohol 
exposure during the first trimester suggests that volumetric measurement of cranial bones may be 
a novel biomarker for binge alcohol exposure during the first trimester to help identify non-
dysmorphic children with FASD.
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Introduction
The teratogenic effects of alcohol abuse during pregnancy were formally identified as fetal 
alcohol syndrome (FAS) about four decades ago (Jones & Smith, 1973). FAS is diagnosed 
primarily based on three criteria: 1) presence of at least two of three characteristic 
dysmorphic facial features (smooth philtrum, thin upper lip, and short palpebral fissures); 2) 
growth deficits in height and/or weight; and 3) structural, neurologic, or functional central 
nervous system (CNS) abnormalities (Bertrand, Floyd, & Weber, 2005; Wattendorf & 
Muenke, 2005). It is now recognized that the large majority of children with untoward 
effects from prenatal alcohol exposure do not fully meet the criteria for a diagnosis of FAS, 
but still express a broad range of skeletal, neurological, developmental, behavioral, or 
learning abnormalities (Aase, Jones, & Clarren, 1995; Astley & Clarren, 2000; Sokol & 
Clarren, 1989). In 2004, the designation fetal alcohol spectrum disorders (FASD) was 
adopted as an umbrella term to encompass the full range of effects resulting from prenatal 
exposure to alcohol, with FAS being the most severe (Riley & McGee, 2005).
In the United States, FASD is the leading cause of preventable birth defects and 
developmental disorders (NIAAA, 2012), with a prevalence ranging from 1% of all births 
(Hoyme et al., 2005; Leibson, Neuman, Chudley, & Koren, 2014) to as high as 2–5% (May 
et al., 2009). FASD places a large burden on the economy, with estimates of the cost as high 
as $4 billion annually due to health care, lost productivity, and special education (Hoyme et 
al., 2005; Lupton, Burd, & Harwood, 2004). Despite extensive efforts to inform the public 
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about the risks of alcohol use during pregnancy, 7% of approximately half a million 
pregnant women surveyed had consumed alcohol in the previous 30 days and 1.4% reported 
binge drinking (CDC, 2012). Over a span of nearly 20 years, binge drinking among pregnant 
women has not significantly declined (CDC, 2009).
Optimal management of children with FASD depends on accurate identification of the full 
spectrum of children adversely affected by prenatal alcohol exposure. Diagnosis of FAS 
through clinical screening relies on trained recognition or anthropometric measurements of 
dysmorphic features of soft tissue structures of the face, yet children with FAS constitute 
fewer than 10% of all children with FASD. Reliable indicators of adverse effects of prenatal 
alcohol exposure are needed to help identify the much larger number of children with FASD 
who do not meet the facial dysmorphology criterion. Quantitative analysis of craniofacial 
bones, which are derived from embryonic neural crest cells that are sensitive to alcohol 
exposure during neurulation (Smith, Garic, Flentke, & Berres, 2014), provides a potential 
approach for identifying a more sensitive indicator. Relatively little work has been done to 
evaluate the underlying craniofacial bones, and its potential use as a quantitative indicator to 
identify children with FASD is largely untapped.
Binge drinking during the first trimester (including prior to pregnancy recognition) is the 
most common pattern of risk drinking in women of childbearing age (Conover & Jones, 
2012; Maier & West, 2001; Ramadoss, Hogan, Given, West, & Cudd, 2006). Craniofacial 
bone changes are an appropriate candidate as a structural biomarker for binge drinking, in 
part because of the spatiotemporal links between embryonic CNS and craniofacial 
development during the first trimester. Bones that form the neurocranium (frontal, parietal, 
and occipital bones) are derived principally from the neural crest and paraxial mesoderm, 
whereas bones that form the viscerocranium (mandible, maxilla, nasal, lacrimal, and jugal 
bones) originate primarily from the first two pharyngeal arches (Moore, 2013). During 
neurulation, neural crest cells originate at the junction of the neural folds and eventually the 
cells migrate to various locations throughout the embryo to form body structures (Smith et 
al., 2014). A subset of neural crest cells, cranial neural crest cells, forms structures of the 
face (bones, cartilage, and cranial nerves) (Sulik, Cook, & Webster, 1988), and are highly 
sensitive to alcohol. Damage to these cells results in dysmorphic craniofacial features and 
some associated brain abnormalities associated with FAS (Cartwright & Smith, 1995; 
Rovasio & Battiato, 1995; Smith, 1997).
In humans, key events over the first trimester of pregnancy (O'Rahilly & Müller, 1996) 
include neurulation (spanning postfertilization days 22–31), which involves formation of the 
neural tube and neural crest, with anterior neuropore closure by day 30. Emergence of the 
full five-vesicle stage is evident at 5 weeks, along with formation of the pontine flexure, 
optic cup, and nasal pit. Formation of the telencephalic cortical plate begins at 7–8 weeks 
with the appearance of the five zones of the emerging cerebral cortex (marginal, cortical 
plate, subplate, subventricular, and ventricular zones). By comparing the timing of the same 
events during embryonic development in sheep (that have a 147-day gestation), it is possible 
to establish temporal equivalence in sheep to the first 8 weeks of human development. In 
sheep, neural tube formation extends into the 3rd gestational week and the anterior 
neuropore closes by gestational day (GD) 21. The five-vesicle stage is evident in the 4th 
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gestational week, while the cortical plate begins forming in the lateral wall of the 
telencephalon at GD35. By GD40, the lateral wall has formed a defined cortical plate and 
the five zones of the emerging cerebral cortex are evident (Reynolds & Møllgård, 1985). 
Comparatively, the first 40 days of embryonic development in the sheep are roughly 
equivalent to the first 8 weeks of human development.
Experimental animal models, primarily mouse models, have shown that binge-like alcohol 
exposure during the first trimester equivalent is sufficient to induce abnormal craniofacial 
development. These studies have identified key roles of dose and timing of prenatal alcohol 
exposure in producing craniofacial effects that model some of those seen in FAS (Sulik, 
1984; Sulik et al., 1988). Specifically, they have shown quantitatively that measurable 
craniofacial changes do occur (Anthony et al., 2010; Hernandez-Guerrero, Ledesma-Montes, 
& Loyola-Rodriguez, 1998; Lipinski et al., 2012; Robin & Zackai, 1994). A major goal of 
the current study was to extend this approach to a well-defined sheep model of binge alcohol 
exposure during a portion of the first trimester equivalent, to assess whether quantitative 
analyses of craniofacial bone volumes using computed tomography (CT) in 6-month-old 
(peripubertal) lambs could accurately predict exposure.
In this study, sheep were evaluated at 6 months of age because we wanted a target age 
comparable to middle school-aged children about to enter puberty during early adolescence. 
Sheep reach puberty when they attain 50–70% of their mature body weight, typically 
between 7–8 months of age, depending on breed (The Merck Veterinary Manual, 2005). 
Therefore, the developmental status of these lambs may be analogous to children in their 
middle-school years with undiagnosed FASD that have developmental, behavioral, and/or 
learning deficits often identified by educators. Additionally, we sought to compare the 
relative accuracy of classifications of prenatal alcohol exposure through a single CT scan, 
which allowed measurement of both cranial bone volumes and linear distance measures 
taken from bone (cranial) and soft tissue (facial) landmarks, along with cranial 
circumference. If confirmed, these quantitative approaches in this sheep model could 
provide new indices of the effects of prenatal alcohol exposure that may prove more 
sensitive than traditional FAS diagnostic indices (head circumference; facial 
morphometrics). This could translate into improved identification of children with FASD.
Measures evaluated in the current study include the volume of the bones of the 
neurocranium and viscerocranium, along with linear measurements of the skull, face, and 
cranial circumference. CT was utilized because it is non-invasive, readily available in most 
hospitals, produces high-resolution, three-dimensional images, and one scan allows 
measurement of bony and soft tissue structures of the face. CT has been effectively used to 
study fixation artifacts in embryologic studies (Schmidt et al., 2010) and recently in studies 
of craniofacial dysmorphology in mouse models of FASD (Kaminen-Ahola et al., 2010; 
Shen et al., 2013). Repeated weekend binge drinking (3 consecutive days per week) over the 
first 8 weeks of human pregnancy was modeled from GD4-41 in the sheep with two binge-
like alcohol treatments. The first treatment modeled heavy binge drinking (2.5 g/kg per day, 
peak blood alcohol concentrations [BACs] above 250 mg/dL) and the second treatment 
modeled more typical binge drinking (1.75 g/kg per day, peak BACs around 200 mg/dL). 
We hypothesized that, relative to the control groups, lambs given binge-like prenatal alcohol 
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exposure would: 1) have reduced CT-derived volumes of the skull bones; 2) have reduced 
cranial circumferences; 3) have altered craniofacial morphometrics of bone as well as face; 
and 4) be classified accurately in terms of prenatal alcohol exposure based on one or more of 
these measures. Because FAS is often associated with binge drinking during the first 
trimester, comparisons between the two binge treatment conditions could help determine 
whether more intense binge exposure episodes produce increasingly severe effects on 
craniofacial morphometrics or skull bone volumes.
Materials and methods
Animals
All animals and experimental procedures were approved by the Institutional Animal Care 
and Use Committee (IACUC) at Texas A&M University. Prior to breeding, Suffolk ewes 
(aged 2–5 years) received multi-species Clostridium bacterin-toxoid (Covexin 8, Intervet/
ScheringPlough Animal Health, Summit, NJ) 2 mL intramuscularly, albendazole (Valbazen 
Suspension 7.5 mg/kg, Pfizer Animal Health, New York, NY) 0.75 mL/25 lb. of body 
weight orally, and ivermectin (Ivomec Drench for Sheep 0.8%, Merial, Duluth, GA) 3 
mL/26 lb. body weight orally. The day of mating (the day that the ewes were marked by the 
ram) was designated as GD 0, and ewes entered the experiment the next day. Ewes were 
penned individually for the experiment but had visual contact at all times with herd mates in 
adjacent pens in an environmentally regulated facility (22°C and a 12:12-h light/dark cycle). 
Ewes entering the experiment were randomly assigned to one of four treatment groups: 
normal control (NC), saline control (SC), binge alcohol (BA), or heavy binge alcohol 
(HBA). Pregnancy was confirmed ultrasonographically on GD25, and if ewes were not 
pregnant, they were removed from the experiment. Ewes were fed a “complete” ration 
(TAMU Ewe Ration, Nutrena, Cargill, Minneapolis, MN) designed to meet 100% NRC 
requirements as calculated by ARIES (software version 2007, University of California, 
Davis) and had free access to drinking water. Maternal food consumption was monitored 
daily. All subjects consumed all feed offered.
Just before parturition, ewes were moved to a covered pen outside where they lambed 
naturally. At birth, newborn lambs were weighed and measured, and their navels were 
dipped in iodine (VetOne Stronger Iodine, 7%, MWI, Meridian, ID). They were also given 
oxytetracycline (Liquamycin®, LA-200®, 200 mg/mL, Pfizer Animal Health, New York, 
NY) 1 mL intramuscularly and selenium/vitamin E (BO-SE®, 1 mg/mL, Intervet/Schering-
Plough Animal Health, Summit, NJ) 0.5 mL subcutaneously. Each ewe was checked for 
satisfactory milk production, and lambs were closely monitored for nursing, weight gain, 
and health status over the next 2 months. At 1 and 2 months of age, lambs were vaccinated 
using multi-species clostridium bacterin-toxoid (Covexin 8, Intervet/Schering-Plough 
Animal Health, Summit, NJ) 2 mL intramuscularly. Nursing lambs and ewes remained 
together until the lambs reached 2 months of age, at which time they were separated from 
their mothers and weaned. Ewes were removed from the premises, and weaned lambs 
remained in the same outdoor covered pens for the rest of the study. At weaning, lambs 
received moxidectin (Cydectin® Oral Drench for Sheep 0.1%, 1 mg/mL, Boehringer 
Ingelheim, St. Joseph, MO) 0.2 mL/kg body weight orally, amprolium (Corid® 9.6% Oral 
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Solution, Merial, Duluth, GA) 0.5 mL/kg orally once daily for 10 days, and vitamin B1 
(Thiamine Hydrochloride, 500 mg/mL, Rafter 8 Products, Calgary, Alberta, Canada) 1.5 mL 
subcutaneously once daily every third day for a total of four treatments. Weaned lambs were 
fed a “complete” ration (Ringmaster Start-To-Finish Show Lamb Pellets, Nutrena, 
Minneapolis, MN) designed to meet 100% NRC requirements as calculated by ARIES 
(software version 2007, University of California, Davis) and had free access to drinking 
water. At 6 months of age, lambs were euthanized using sodium pentobarbital 
(Beuthanasia®, Intervet/Schering-Plough Animal Health, Summit, NJ) 75 mg/kg 
intravenously. Computed tomography (CT) imaging was performed immediately after 
euthanasia.
Treatment groups
Ewes (n = 36) were randomly assigned to one of four treatments – normal control (NC) 
group (n = 8 ewes), the saline control (SC) group (n = 8 ewes), the binge alcohol (BA; 1.75 
g/kg) group (n = 8 ewes), and the heavy binge alcohol (HBA; 2.5 g/kg) group (n = 12 ewes). 
An intravenous catheter (16-gauge, 5.25-inch Angiocath™; Becton Dickinson, Sandy, UT) 
was placed into the jugular vein of each ewe (except for the NC group) on GD 4. Beginning 
on this day, alcohol (2.5 or 1.75 g/kg body weight) or saline was administered intravenously 
over a 1-h period via a pump (VetFlo® 7701B IV Vet Infusion Pump, Grady Medical, 
Temecula, CA). The alcohol solution was prepared by adding 95% ethanol to sterile 0.9% 
saline to achieve a 40% w/v alcohol solution. Solutions were prepared under aseptic 
conditions and were passed through a 0.2-μm bacteriostatic filter. The saline control group 
received an infusion of isotonic saline (0.9%) that was equal in volume to the alcohol 
infusions. Infusions were administered on three consecutive days per week from GD4–41, 
followed by four days without treatment (18 treatments total). Lambs produced from ewes in 
the four treatment groups that entered the imaging study included 8 NC lambs (1 female, 7 
males), 8 SC lambs (4 females, 4 males), 8 BA lambs (6 females, 2 males), and 12 HBA 
lambs (6 females, 6 males).
Maternal blood alcohol concentration
Blood was drawn from the jugular vein of each ewe 1 h after alcohol infusions began to 
measure peak BAC as previously described (Washburn, Sawant, Lunde, Wu, & Cudd, 
2013). A 20-μL aliquot of blood was collected in a microcapillary tube and transferred into a 
vial containing 0.6 N perchloric acid and 4 mM n-propyl alcohol (internal standard) in 
distilled water. The vial was tightly capped with a septum-sealed lid and stored at room 
temperature until analysis by headspace gas chromatography (Varian Associates model 
3900, Palo Alto, CA) at least 24 h after collection.
Computed tomography imaging
Images were acquired on a computed tomography (CT) scanner (Biograph mCT®, Siemens 
Medical, USA) that operated at 120 kVp and 300 mA maximum cube current. In the 
standard mode of operation, the distance from the detector to the source was 1.0856e+003 
mm and source to subject distance was 595 mm. The data collection diameter of the scan 
field of view (SFOV) was 500 mm, and the reconstruction diameter of the display field of 
view (DFOV) was 300 mm. The matrix was 512 × 512, pixel size was 0.59 mm, slice 
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thickness was 1 mm, and voxel volume was 0.348 mm3. The image acquisition was 
performed on animals immediately after euthanasia. Before animal scanning, daily system 
calibration was performed for accuracy. Long-term scanner maintenance was performed in 
compliance with the operating manual (Siemens Biograph mCT® versions VG10A, 
VG21A, VG30A, VG40A, chapters 7 and 12).
Image analysis
Amira Software (Visage Imaging, Inc., San Diego, CA) was used for bone segmentation and 
acquisition of skull measurements and craniofacial measurements. After three-dimensional 
(3D) reconstruction of the head scan, bony tissues were segmented (identified) as previously 
described (Shen et al., 2013). A threshold of 160 HU (Hounsfield Units) was used to 
complete all bony tissue segmentations and skull measurements, and −350 HU was used for 
soft tissue facial measurements. Amira Software was used to visualize soft tissue structures 
and underlying craniofacial bones and then manually extracted a total of 29 measurements: 
1) nine 2D skull craniofacial measurements (distance, mm): upper facial depth, lower facial 
depth, orbital height and width, minimal frontal width, bitragal width, bigonial width, 
interorbital distance, and nasal length (see Table 1 and Fig. 1); 2) ten 2D craniofacial soft-
tissue measurements (distance, mm): nasal width, nasal length, nasal bridge length, philtrum 
length, lower facial height, mid-facial depth, lower facial depth, palpebral fissure length, 
inner canthal width, and outer canthal width (see Table 1 and Fig. 2); 3) eight 3D individual 
skull bone volumes plus total skull bone volume (volume; mm3): mandible, frontal, parietal, 
occipital, maxilla, nasal, lacrimal, and jugal bones (see Fig. 3), with total skull the sum of all 
eight; and 4) 2D cranial circumference (distance, mm). Though cranial circumference was 
obtained as part of the skull distance measures in the lambs, it was separated from the 
craniofacial measures for the purposes of initial analyses. This was done because head 
circumference is typically obtained separately from the dysmorphology exam in clinical 
settings as part of the diagnostic measures to identify children with FAS, and it is interpreted 
separately from facial dysmorphology (Jones et al., 2009). All measurements were taken by 
one of the authors (SMB) who was blinded to the treatment groups. To decrease 
measurement error, each measurement was repeated in triplicate with subsequent measures 
taken only if the first three measurements differed by >2mm. In instances in which >3 
measurements were taken, outliers >2mm were not used. The nineteen 2D craniofacial 
measurements and the cranial circumference measurement were acquired utilizing a 
measurement tool in Amira. The eight bones of the skull were manually segmented, and 
their volumes were calculated based on the segmentation results. For the bilateral linear 
measurements of the face and skull, preliminary analyses indicated there were no significant 
differences between the left and right sides, so only the left side of all bilateral 
measurements of the face and skull were used for subsequent analyses. Total skull bone 
volume was calculated by adding all of the individual bone segmentations together (left and 
right sides where applicable). Ear measurements were not taken because the ears were 
inadvertently cropped in the CT output file.
Statistical analysis
Given the unequal numbers of males and females in the NC and BA groups and the low 
number of lambs of each sex across treatment groups overall, the power to detect potential 
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sex differences was very limited. The data were first screened for potential differences 
between males and females. This was to determine whether the male and female data could 
be combined within groups for the purposes of statistical analysis without confounding the 
analysis of prenatal treatment. The NC group had only one female and the BA group had 
only two males. The within-group ranking of the data of those subjects was determined and 
each fell within the range of the majority sex of the group. Therefore, the individual data did 
not skew the within-group distribution for any measure for either the NC or BA groups. For 
the two groups with equal numbers of males and females (SC and HBA), a two-way 
analyses of variance (ANOVA) with sex and treatment as grouping factors was calculated. 
None of the measures showed a significant main or interactive effect of sex, so the data of 
males and females were combined within groups for subsequent analyses of variance.
Treatment effects on measurements of skull bone volumes, skull distances, face distances, 
and cranial circumference were first analyzed with one-way between-subjects ANOVA 
using Bonferroni-corrected alpha levels to set the significance level within each set of data. 
Thus, for the nine skull bone volumes and nine skull distance measures, a Bonferroni-
corrected alpha level of 0.0056 (= 0.05/9) was used for the nine univariate ANOVAs. For 
the ten face distance measures, the Bonferroni-corrected alpha level was 0.005 (= 0.05/10). 
For cranial circumference, the alpha level was 0.05. Measures that met the Bonferroni-
corrected alpha level on the univariate test were then analyzed using pairwise comparisons 
among the four treatments within each measure, and the multiple comparisons were 
corrected by the Holm-Sidak method (p < 0.05). In addition, two different one-way 
between-subjects analyses of covariance (ANCOVA) were calculated for individual skull 
bone volumes. The first included covaried total skull bone volume and sex, while the second 
were covaried cranial circumference and sex. Separate ANCOVAs were also calculated for 
the facial and skull bone linear distances, covarying for cranial circumference and sex. The 
main purpose of these covariance analyses was to determine the extent to which individual 
skull bone volumes (or craniofacial linear measures) could provide quantitative evidence of 
the effects of binge alcohol treatment beyond that which might be associated with reduced 
head size, as well as to control for any influences of sex differences. This approach follows a 
publication that assessed similar measures in a prenatal mouse model (Shen et al., 2013). To 
determine whether total bone volume provides a better identification of alcohol-exposed 
lambs than cranial circumference (akin to head circumference in FAS screening), the 10th 
percentile was calculated for each measure. Each distribution, total skull bone volume, and 
cranial circumference, from the NC and SC groups (not significantly different) was 
combined to form control distributions for each measure. Lambs in the BA and HBA groups 
were then classified based on whether or not they were <10th percentile of the control 
distribution for each measure (similar to the FAS screening cutoff). The relative sensitivity 
of the two measures was determined by comparing the number of lambs in the 10th 
percentile of the two measures using Fisher's Exact Test.
Discriminant analysis
Univariate discriminant analyses of the craniofacial bone measures were examined for six 
pairwise comparisons: NC vs. HBA, NC vs. BA, NC vs. SC, SC vs. BA, SC vs. HBA, and 
BA vs. HBA. Univariate Receiver Operating Characteristic (ROC) analysis was 
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implemented using Matlab (The MathWorks, Inc., Natick, MA) and was performed on each 
of the following measures: 1) nine skull volume measures, 2) nine skull distance measures, 
and 3) ten face distance measures; cranial circumference was included in each of the three 
data sets. Area under the ROC curve (AUC) was reported. The best overall classification 
accuracy for percent of all animals correctly classified on the ROC curve, its corresponding 
sensitivity for percent of cases correctly classified, and its corresponding specificity for 
percent of controls correctly classified, were also reported in each comparison.
Results
Maternal blood alcohol concentration
The mean ± SEM maternal BACs at the end of alcohol infusion (1 h; point in time at which 
BACs are known to peak) were significantly higher in the HBA treatment (280.0 ± 9.7 
mg/dL) compared to the BA treatment (198.9 ± 8.6 mg/dL) (p = 0.001).
Fetal and 6-month-old body weights
There were no significant differences between groups with regard to fetal birth weight (NC, 
5.71 ± 0.35 kg; SC, 5.74 ± 0.33 kg; BA, 5.13 ± 0.49 kg; HBA, 4.68 ± 0.31 kg) and 6-month-
old body weight (NC, 36.59 ± 4.33 kg; SC, 38.72 ± 4.04 kg; BA, 34.09 ± 2.25 kg; HBA, 
33.02 ± 1.71 kg).
Correlations among measures
As expected, Pearson correlations among all nine skull volume measures and the cranial 
circumference were strongly positive (see Table 2), and all were statistically significant (p < 
0.001). The correlation coefficients ranged from r = 0.640, between the nasal and parietal 
bones, to r = 0.955 between total skull bone volume and frontal bone. Each of the bone 
volumes were highly correlated with cranial circumference (r = 0.716 to 0.939).
Pearson correlations among the nine skull distance measurements and cranial circumference 
were all positive (see Table 3), and 53% were statistically significant (p < 0.001). The 
significant correlations ranged from r = 0.530, between the interorbital distance and orbital 
height, to r = 0.897 between the bitragal width and cranial circumference. Notably, all of the 
skull distance measures except orbital width and skull nasal length were significantly 
correlated with cranial circumference (r = 0.579 to 0.897). Orbital width did not correlate 
significantly with any of the other skull measures and skull nasal length significantly 
correlated with only one skull measure (lower facial depth).
Pearson correlations among ten facial measurements and the cranial circumference were all 
positive and 43.6% were statistically significant (see Table 4). The significant correlation 
coefficients (p < 0.001) ranged from r = 0.460, between the outer canthal width and lower 
facial depth, to r = 0.977 between the nasal bridge length and facial nasal length. All of the 
facial distance measures except the lower facial height and palpebral fissure length were 
significantly correlated with the cranial circumference (r = 0.543 to 0.837). Palpebral fissure 
length did not correlate significantly with any of the other facial measures.
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Pearson correlations between the ten facial distance measures and the nine underlying skull 
distance measures resulted in 29 positive correlations (p < 0.001) out of 90 (32%, see Table 
5). A majority of these 29 reflected common structural features between facial landmarks 
and underlying skull structures (e.g., lower facial depth in the face correlated with the same 
measure in bone; inner and outer canthal widths in facial measures correlated with bone 
measures of minimal frontal width, bitragal width, bigonial width, and interorbital distance; 
facial nasal length correlated with bone lower facial depth, etc.). Mid-facial depth (akin to 
the “flattened mid-face” of FAS) significantly correlated with six of the nine bone distance 
measures. Palpebral fissure length and philtrum length are two facial measures most directly 
comparable to measures used in FAS dysmorphology evaluations. Palpebral fissure length 
was not significantly correlated with any underlying bone measure and philtrum length was 
significantly correlated only with orbital height.
Skull bone volumes and cranial circumference
As shown in Fig. 4, significant effects of prenatal treatment were evident in eight of the nine 
volumetric skull measures (Bonferroni-corrected α = 0.0056) and in the cranial 
circumference measure (p < 0.05). Bones with significant treatment effects included the 
mandible (F[3,35] = 15.988, p < 0.001), frontal (F[3,35] = 24.906, p < 0.001), parietal 
(F[3,35) = 26.724, p < 0.001), occipital (F[3,35] = 18.285, p < 0.001), maxilla (F[3,35] = 
12.850, p < 0.001), lacrimal (F[3,35] = 16.894, p < 0.001), jugal (F[3,35] = 14.740, p < 
0.001), total skull bone volume (F[3,35] = 23.944, p < 0.001), and cranial circumference 
(F[3,35] = 15.089, p < 0.001). Pairwise group comparisons (Holm-Sidak p < 0.05) 
confirmed that the bone volumes of the HBA and BA groups were significantly reduced 
relative to the NC and SC groups for all skull bones except the nasal bone, the total skull 
bone volume, and the cranial circumference. There were no significant differences between 
the BA and HBA groups, or between the NC and the SC groups.
Covariance analyses using either total skull bone volume or cranial circumference and sex as 
covariates were used to assess alcohol treatment effects on individual skull bone volumes. 
This was done to determine if the individual bone volumes would remain significant after 
the effects of head size or total skull bone volume and sex differences were removed. After 
covarying for total skull bone volume and sex, treatment effects on volumetric skull 
measures were no longer significant (Bonferroni-corrected α = 0.00625). This was 
consistent with the strong correlations between total skull bone volume and the volume of 
each individual bone. After covarying for cranial circumference and sex, significant effects 
among the four treatment groups were found in four of the nine volumetric skull measures 
(Bonferroni-corrected α = 0.0056; Fig. 5). These included the frontal, parietal, and occipital 
bones, as well as the total skull bone volumes. Pairwise comparisons (Holm-Sidak p < 0.05) 
showed the HBA treatment differed from both NC and SC groups for the parietal and 
occipital bones. The occipital bone was the only bone volume measure to show a 
significantly greater reduction in the HBA treatment compared to the BA treatment, 
suggesting a dose-dependent effect. Thus, when variance associated with cranial 
circumference (and sex) was statistically controlled, the parietal and occipital bones still 
distinguished the HBA group from the NC and SC groups.
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Craniofacial distance measures
Significant treatment effects were evident in five of the nine skull distance measures 
(Bonferroni-corrected α = 0.0056; Fig. 6), including the upper facial depth (F[3,35] = 8.997, 
p < 0.001), bitragal width (F[3,35] = 10.949, p < 0.001), interorbital distance (F[3,35] = 
7.806, p < 0.001), and nasal length (F[3,35] = 5.575, p < 0.001). Holm-Sidak pairwise group 
comparisons showed significant differences (p < 0.05) between the BA and HBA groups and 
the NC and SC groups for upper facial depth, bitragal width, and interorbital distance. No 
significant differences were found between the BA and HBA groups, or between the NC and 
SC groups in these three skull distance measures. Bigonial width showed differences 
between the HBA and SC groups, but HBA did not differ significantly from NC. Nasal 
length showed differences between the BA and HBA groups, but neither of those was 
significantly different from either the NC or SC groups.
For the facial distance measures, significant treatment effects were found in five of the ten 
measures (Bonferroni-corrected α = 0.005; see Fig. 7), including the philtrum length 
(F[3,35] = 5.244, p < 0.001), mid-facial depth (F[3,35] = 6.946, p < 0.001), lower facial 
depth (F[3,35] = 5.195, p < 0.001), inner canthal width (F[3,35] = 15.097, p < 0.001), and 
outer canthal width (F[3,35] = 6.618, p < 0.001). However, follow-up Holm-Sidak pairwise 
group comparisons for these five measures indicated that only the inner canthal width 
showed significant reductions (p < 0.05) in both alcohol-exposed groups compared to the 
two control groups. None of the other measures showed significant differences between the 
alcohol-exposed and both control groups. Covariance analyses were performed to evaluate 
the effects of cranial circumference and sex on the nine skull distance measures (Bonferroni-
corrected α = 0.0056) and the ten face distance measures (Bonferroni-corrected α = 0.005). 
None of the skull or face measures remained significant between the alcohol-exposed groups 
and the control groups.
Discriminant analyses
Area under ROC curve (AUC) results from the univariate ROC analyses are shown in Table 
6A, 6B, and 6C. Several bone volumetric measures were identified as best predictors in 
classifying between alcohol-exposed groups and control groups across the ROC analysis of 
the six treatment pairs (see Table 6A). The mandible, frontal bone, parietal bone, and total 
skull bone volumes achieved an AUC of 0.99–1.0, with the best overall accuracy of 100% 
(sensitivity 100%, specificity 100%). The occipital bone provided the best discrimination 
between the BA and HBA groups (AUC = 0.708; accuracy of 75%, sensitivity and 
specificity of 75%). For the skull distance measures (see Table 6B), the interorbital distance 
was the best predictor in distinguishing between an alcohol and control treatment (AUC 
between 0.984–1.0) with overall accuracies between 93.8–100% (sensitivities between 87.5–
100%, specificities of 100%). For the facial soft-tissue measures (see Table 6C), the inner 
canthal width was the best predictor in distinguishing between an alcohol and control 
treatment. The AUC ranged between 0.906–1.0, and accuracies between 90–100% 
(sensitivities 87.5–100%, specificities 75–100%). The cranial circumference was the next 
best predictor in distinguishing between an alcohol and control treatment, with AUC ranging 
between 0.875–0.984, and accuracies between 93.8–95% (sensitivities 87.5–100%, 
specificities 87.5–100%). Of the skull and facial distance measures, the best predictors to 
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classify between the BA and HBA groups were the skull nasal length (AUC 0.802; overall 
accuracy of 75%; sensitivity 58.3% and specificity 100%) and nasal bridge length (AUC 
0.781; overall accuracy of 75%; sensitivity 83.3% and specificity 62.5%).
Relative sensitivity of total skull bone volume and cranial circumference
From the discriminant analysis (above and Table 6A), total skull bone volume was 100% 
accurate in classifying alcohol-exposed and control lambs, more accurate than the cranial 
circumference (with which it was highly correlated, r = 0.939). The effect size of the alcohol 
treatment for total skull bone volume (Cohen's d = 2.81) was larger than the effect size for 
cranial circumference (Cohen's d = 2.23). In the context of potential usefulness of total skull 
bone volume as a screening measure to help identify a larger proportion of individuals with 
FASD, the relative sensitivity of total skull bone volume (a novel candidate measure) was 
compared to the cranial circumference (similar to head circumference in clinical screening 
in which scores <10th percentile are used to help diagnose FAS). Lambs of the NC and SC 
groups were combined (n = 16), and the 10th percentile of this combined control group was 
established for both the cranial circumference measure (390.7 mm) and the total skull bone 
volume measure (254,358 mm3). Alcohol-exposed lambs of both groups (BA and HBA) 
were then predicted based on whether or not they were less than the 10th percentile cutoff. 
For cranial circumference, 14 out of 20 alcohol-exposed lambs (70%) were under the cutoff 
(7/8 BA; 1/12 HBA), whereas all 20 of the alcohol-exposed lambs (100%) were under the 
cutoff for total skull volume. A two-tailed Fisher's Exact Test confirmed that the 
classification based on total skull bone volume was significantly more sensitive than the one 
based on cranial circumference (p = 0.020).
Discussion
Although facial dysmorphology is a cardinal feature of FAS, children with FASD may not 
have identifiable features or their facial features may be too subtle to detect reliably on 
clinical exam (Streissguth, 1994; Streissguth et al., 1991; Wattendorf & Muenke, 2005). As 
a result, many children exposed prenatally to alcohol are not recognized as having FASD 
until later in adolescence when unruly behavior or developmental and learning disabilities 
become problematic. This study of lambs born to ewes given alcohol during the first 
trimester equivalent tested whether more sensitive structural indices could be achieved from 
a single CT scan of the head. Quantitative measures obtained from this scan provide a novel 
biomarker for prenatal alcohol exposure utilizing individual bone volumes and collectively, 
the total skull bone volume. The scan also allows for morphometric measures, skull bone 
and soft tissue, which model anthropometric studies in humans (Astley, 2006; Hoyme et al., 
2005; Moore et al., 2007) and rodents (Anthony et al., 2010; Shen et al., 2013).
An important discovery from this sheep model is that quantitative volume measures of the 
bones of the neurocranium may be one of the most sensitive structural indicators of the 
effects of binge alcohol during the first 8 weeks of human pregnancy. Both the binge alcohol 
(BA) and heavy binge alcohol (HBA) treatments resulted in significant and severe 
reductions in total skull bone volume, volumes of the frontal, parietal, occipital, maxilla, 
mandible, lacrimal, and jugal bones, as well as cranial circumference. After statistically 
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controlling for smaller cranial circumference in the alcohol-exposed groups, significant 
reductions in the volumes of the parietal and occipital bones were evident in the HBA group. 
Discriminant analysis showed that the frontal bone, parietal bone, and total skull bone 
volumes achieved 100% sensitivity and specificity in predicting prenatal treatment (alcohol 
or control). Volumes of these bones were better predictors of alcohol exposure than cranial 
circumference, and were consistent with the greater effect size of alcohol treatment for total 
skull bone volume (d = 2.81) and cranial circumference (d = 2.23). All alcohol-exposed 
lambs were at or below the 10th percentile of the control lamb distribution for total skull 
bone volume. The sensitivity of classification of alcohol-exposure based on this 10th 
percentile cutoff for total skull volume was significantly better than a similar classification 
based on a 10th percentile cutoff for cranial circumference. Taken together, these findings 
suggest that CT-derived measures of neurocranial bone volumes may provide a novel 
method for identifying children with FASD.
Cranial circumference in this model is directly parallel to reduced head circumference in 
FAS. Head circumference is routinely evaluated on a physical exam (Hoyme et al., 2005; 
Jones et al., 2010) and is a simple, direct, and easily obtained measure that has population 
norms. The smaller head circumference found in children with FAS (Carter, Jacobson, 
Sokol, Avison, & Jacobson, 2013; Ortega-García et al., 2012) has been modeled in mice 
exposed to alcohol prenatally (Shen et al., 2013) and was replicated in this study. However, 
the results in this study indicate that total skull volume is more sensitive and more accurate 
than cranial circumference in predicting prenatal alcohol exposure, even though the two 
measures were strongly correlated (r = 0.939). These findings suggest that, if skull bone 
volume determinations could safely become available in alcohol-exposed and non-exposed 
children, the neurocranium bone volume would be a more accurate predictor of prenatal 
alcohol exposure than either facial dysmorphology or head circumference.
Although CT scanning of the head is not without risk and segmentation of the skull bones 
may be clinically demanding, quantitative CT scans eventually could provide better 
identification of prenatal alcohol exposure in clinical screening of children at risk for FASD. 
The lack of age-specific norms for cranial bone volumes and the potential risk of 
unnecessary radiation exposure with elective use of CT in children currently limit 
application of this approach in helping identify children with FASD. While it may be 
possible to build a reasonably large normative data base from CT scans in children 
undergoing head CT for medical purposes, perhaps it is more difficult to justify non-
diagnostic CT scans for FASD (or other) children. Nevertheless, research and development 
efforts in biomedical imaging are improving safety by lowering scan times and creating new 
technology that reduces radiation exposure. For example, electron-beam CT is a relatively 
new technology. A study in children found that multi-detector CT delivered higher doses of 
radiation compared with the doses delivered in electron-beam CT (Hunold et al., 2003). In 
time, as electron-beam CT and other technology becomes more clinically available, it is 
reasonable to expect that the safety of CT will sufficiently outweigh the risks and that the 
quantitative approaches used in this study will become clinically feasible on a routine basis.
Prenatal alcohol exposure significantly affected all three of the neurocranium bones (frontal, 
parietal, and occipital) and four of the five viscerocranium bones (maxilla, mandible, 
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lacrimal, jugal, but not nasal). Overall, the bone volume changes were highly correlated, 
such that in the analysis using total skull bone volume as a covariate, none of the individual 
bone volumes remained significant. However, the neurocranium bone volumes were 
generally better predictors of prenatal alcohol exposure in the discriminant analysis, and 
only the parietal and occipital bones distinguished the HBA group after the effects of cranial 
circumference were statistically removed. The neurocranium bones are directly and 
anatomically related to the three skull distance measures (upper facial depth, bitragal width, 
interorbital distance) and one facial measure (inner canthal width) that were significantly 
reduced in the binge and heavy binge alcohol treatments. Thus, it appears that prenatal binge 
alcohol exposure effects on head and skull measures may be more directly related to growth 
of the neurocranium than the viscerocranium, and relative to routine FAS screening 
measures, alcohol-induced reductions in the neurocranium volumes may provide better 
detection of prenatal alcohol exposure.
In comparing the two binge alcohol exposure treatments, no significant differences were 
evident in any of the volumetric or linear distances in the BA and HBA treatments in the 
absence of covariance analysis. The two alcohol treatments used in this “weekend binge 
drinking” model of the first 8 weeks of human pregnancy both produced relatively high peak 
blood alcohol concentrations (199 and 280 mg/dL, respectively). Both alcohol treatments 
were equally prone to produce skull volume and craniofacial changes. The 1.75 g/kg per day 
dose was sufficient to induce craniofacial abnormalities. The only differences identified in 
the BA and HBA treatments were from the covariance analysis (with cranial circumference 
and sex as covariates), which statistically controlled for overall effects of head size. In that 
analysis, the HBA treatment produced significantly greater reductions than the BA treatment 
in the adjusted means of the occipital bone volume. The occipital bone was also the most 
accurate predictor in distinguishing between the BA and HBA treatments in the discriminant 
analysis. This suggests that the occipital bone volume may be a sensitive biomarker for 
increasing severity of binge drinking during the first trimester.
In terms of craniofacial distance measures, reductions in three of the nine bone distances 
(upper facial depth, bitragal width, interorbital distance) and one of the ten soft-tissue face 
distances (inner canthal width) distinguished BA and HBA lambs from NC and SC lambs. 
All four measures were highly correlated with cranial circumference. When cranial 
circumference was used as a covariate, none of the measures remained significant between 
the BA and HBA groups and the NC and SC groups. The interorbital distance predicted the 
alcohol-exposed treatments from the control treatments with 93.8–100% accuracy (87.5–
100% sensitivities and 93.8–100% specificities), and the inner canthal width was 90–100% 
accurate (87.5–100% sensitivities and 75–100% specificities). There were significant 
correlations between several facial measures and the underlying bone measures that were 
closely associated with those facial features. Significant reductions in the correlated 
measures of interorbital distance (bone) and inner canthal width (face), as well as the high 
accuracy in classifying prenatal alcohol treatment based on interorbital distance and on inner 
canthal width, suggests that these two measures (associated with reduced distances between 
the eyes) may also help identify children with FASD. These findings are the first report of 
quantitative skull and facial morphometric changes in the sheep model of maternal binge 
alcohol exposure during a portion of the first trimester equivalent.
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A previous rodent study analyzed facial measurements on embryonic day 17 C57BL/6N 
mice and found significant treatment effects in 12 of the 15 measures analyzed. Four 
measures (upper face, mid-face, nasal length, nasal bridge) identified the alcohol group from 
the pair and chow-fed groups (Anthony et al., 2010), which showed only partial 
correspondence to the four measures identified in this sheep study (upper facial depth, 
bitragal width, interorbital distance, and inner canthal width). Differences between the 
mouse model and sheep model outcomes could be explained either by differences in 1) 
alcohol exposure models (with the sheep model involving a more direct experimental 
control over binge-like exposure), 2) the older developmental status of the sheep 
(peripubertal lambs compared to late-fetal mice), or 3) species differences between sheep 
and rodents in how alcohol alters craniofacial development.
A comparable CT study of skull morphology was conducted in 21-day-old C57BL/6J mice 
that showed bone volumes were capable of identifying alcohol-exposed offspring (Shen et 
al., 2013), similar to findings in this study. The mouse model studies, involving maternal 
consumption of alcohol liquid diets, produce prenatal and postnatal growth deficits in 
offspring that can be conflated with craniofacial bone growth deficits. In this sheep model 
paradigm, there were no significant effects on birth weight or postnatal growth of the lambs.
Palpebral fissure length is a cardinal feature to assess FAS in children (Astley, 2006; 
Bertrand et al., 2005; Chudley et al., 2005; Jones & Smith, 1973), yet palpebral fissure 
length was not reliably affected in this sheep model of prenatal alcohol exposure, and it was 
not significantly correlated with cranial circumference or total skull bone volume. The 
results of this study indicate that neither the orbital height, orbital width (bone), or the 
palpebral fissure length (face) were significantly different between alcohol-exposed and 
control lambs. This contrasts with a human study in which significant reductions were found 
in palpebral fissure length, inner canthal width, and outer canthal width (Moore et al., 2007). 
A recent human study concluded that palpebral fissure length and head circumference are 
independent of each other and that short palpebral fissures are likely reduced due to 
forebrain damage, not necessarily due to smaller head size (Jones et al., 2009). In the 
embryonic mouse model, a direct correlation was identified between reduced palpebral 
fissure length and reduced globe size as well as forebrain reduction implicating a correlation 
to forebrain damage (Parnell et al., 2006). Palpebral fissure length in this sheep model was 
not useful in distinguishing between the four treatment groups. In contrast and consistent 
with the human study by Moore and colleagues, the sheep model did find significant 
alcohol-induced reductions in the inner canthal width relative to controls (NC; SC), and the 
outer canthal width was significantly reduced relative to the SC group. This suggests that in 
the sheep model, craniofacial effects are more prominent in measures linked to craniofacial 
and skull width development (inner and outer canthal widths, interorbital widths, bitragal 
width, upper facial depth) rather than direct orbital measures. These differences may reflect 
species differences in response to alcohol exposure, or they may point to a previously 
unrecognized sensitivity of mid-facial width measurements in FASD screening. The Moore 
et al. study (2007) also included a wide range of ages, an ethnically diverse population, and 
unknown maternal drinking history. These sources of variance may have important 
influences on craniofacial morphometry.
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There are many translational advantages of the sheep model of FASD (Cudd, 2005), in 
which dose, pattern, and timing of alcohol exposure are experimentally controlled. The 
resulting blood alcohol concentrations are known and these underscore the translational 
importance of the current findings that identify neurocranium bone volumes as a potential 
biomarker of prenatal alcohol exposure. Sheep model studies are limited by several factors 
that make it difficult to get large sample sizes and adequate sex representation for 
experiments. Studies take longer to complete, are more labor intensive, and are more 
expensive than rodent studies. Despite these limitations, experimental studies can be done 
utilizing the sheep model in a translational role for preclinical studies of FASD. This is due 
to improved ability in controlling and matching the experimental conditions of daily 
patterns, developmental timing of alcohol exposure more similar to humans, and the 
development of measures to advance diagnostic phenotypes of FASD. Sheep have body 
weights and head/brain sizes that are more comparable to humans and they have long 
gestational periods (147 days) closely resembling human gestation (280 days). Sheep also 
have brain development stages in utero that can be matched more directly to prenatal brain 
development in humans (Cudd, 2005). Findings in this study illustrate the translational value 
of the sheep model, confirming that the effects on bone volumes are replicable in multiple 
species, but also provide novel evidence that neurocranium bone volumes may provide an 
optimal structural biomarker of the effects of first trimester binge drinking associated with 
FASD.
To summarize, these results confirmed our hypothesis that CT morphometric analysis is an 
effective tool for detecting prenatal binge alcohol exposure in lambs. Lambs born to ewes 
exposed to alcohol during the period of embryonic development comparable to the first 8 
weeks of human pregnancy had reduced CT-derived volumetrics of the bones and, less 
reliably, reduced facial and skull measures. Discriminant analysis of CT measures could 
identify alcohol-exposed from non-exposed lambs with 100% accuracy. These changes 
correlate to reduced craniofacial bone volumes in the rodent model and reduced head 
circumference in both rodents and humans. Facial measurements in the sheep share some 
similarities in humans with FAS, including reductions in the upper facial depth, bitragal 
width, and inner canthal distance, but other dysmorphic effects seen in humans were not 
reliably produced in this sheep model (palpebral fissure width).
Several findings in this study highlight the potential translational value of the sheep model 
and the development of better diagnostic tools for craniofacial phenotypes of FASD. To the 
extent that CT scans can become feasible in FASD research settings, the findings in this 
study predict several relatively straightforward measures that should accurately identify 
otherwise non-dysmorphic children who experienced binge-like alcohol exposure during the 
first trimester. The best predictors would most likely be segmented bone volumes of the 
neurocranium (frontal, parietal, occipital, or volume of the total skull). These measures 
should have high sensitivity and specificity in classifying prenatal binge-alcohol exposed 
children from non-exposed children. Inclusion of the occipital bone volume may also help 
determine which children were heavily exposed during the first trimester (likely to include 
those diagnosed with FAS). Concurrent use of multiple quantitative CT measures (e.g., 
neurocranium bone volumes together with cranial circumference, interorbital distance, and 
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inner canthal width) may further improve the reliability of classification. Implementation of 
CT morphometrics would also require establishment of age-specific normative data. The 
degree to which these bone structural phenotypes (observed in this study in peripubertal 
sheep) might change over development is not known, and whether they could be applied to 
earlier ages (childhood) or later ages (adolescence or young adulthood) remains to be 
determined. The implication is that development of comparative CT analysis may 
significantly improve the identification of children with FASD, individuals whose status 
otherwise would be either unknown, uncertain, or overlooked.
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Highlights
• CT-derived craniofacial bone volumes and measurements detect alcohol-
exposed lambs
• Alcohol-exposed lambs have reduced cranial circumference and total skull bone 
volume
• Alcohol-exposed lambs have reduced volumes in segmented skull bones (7 out 
of 8)
• Alcohol-exposed lambs have decreased craniofacial measures (4 out of 19)
• Occipital bone volume distinguishes binge exposure from heavy binge exposure 
lambs
• CT has diagnostic potential for quantitating facial dysmorphology in FASD
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Fig. 1. 
Normal control lamb skull (lateral, caudal, and dorsal 3D aspects shown) as visualized with 
Amira Software (Visage Imaging, Inc., San Diego, CA). The 10 skull linear measurements 
obtained from each of the lamb skulls are shown as identified in Table 1.
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Fig. 2. 
Normal control lamb face (rostral and lateral 3D aspects shown) as visualized with Amira 
Software (Visage Imaging, Inc., San Diego, CA). The 10 face linear measurements obtained 
from each lamb are shown as identified in Table 1. The ears have been cropped from the 
image.
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Fig. 3. 
Normal control lamb skull (lateral and caudal 3D aspects shown) as visualized with Amira 
Software (Visage Imaging, Inc., San Diego, CA). The 8 bones segmented for bone volumes 
on each lamb skull are shown. In the lateral view, only the right-sided segmentation is 
visible. Total skull bone volume was calculated by adding together the volume of all of the 
bone segmentations (left and right sides).
Birch et al. Page 23
Alcohol. Author manuscript; available in PMC 2016 November 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Fig. 4. 
Treatment effects on 9 volumetric skull measures and the cranial circumference measure. 
The y-axis indicates the mean volume (± SEM) in mm3 for the 8 segmented bone volumes 
and total skull volume, or length (in mm) for cranial circumference. Note the scale for the 6 
bones in the top panels (maximum of 100,000 mm3) differs from that in the lower panels for 
the lacrimal and jugal bones (maximum of 20,000 mm3). For the bone volumes, the 
ANOVA α level was adjusted to 0.0056 (=0.05/9) for the nine ANOVAs performed, 
followed by the Holm-Sidak method for pairwise comparisons (p < 0.05). For cranial 
circumference, the ANOVA α level was 0.05, followed by the Holm-Sidak method for 
pairwise comparisons (p < 0.05). Significant group differences are indicated within each 
panel. An asterisk (*) indicates that the volumes of two control groups (NC and SC) were 
significantly greater than the two alcohol-exposed groups (BA and HBA); NC and SC did 
not differ from each other, and BA and HBA did not differ from each other.
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Fig. 5. 
Treatment effects on 9 volumetric skull measures while controlling for cranial 
circumference and sex, showing the adjusted group means (± SEM) after removal of the 
influence of the two covariates. The y-axis indicates the adjusted volume in mm3 for the 9 
measures (note scale differences between the top and bottom panels). For bone volumes, the 
ANOVA α level was adjusted to 0.0056 (=0.05/9) for the nine ANOVAs performed, 
followed by the Holm-Sidak method for pairwise comparisons (p < 0.05). For cranial 
circumference, the ANOVA α level was 0.05, followed by the Holm-Sidak method for 
pairwise comparisons (p < 0.05). Significant group differences are indicated within each 
panel. Note that after controlling for effects of differences in cranial circumference, the 
effects of the heavy binge alcohol (HBA) treatment relative to controls were still detectable 
in the parietal and occipital bone volumes, and the HBA even differed from the BA group in 
the occipital bone volume. Significance between NC vs. SC is indicated with a dagger sign 
(†), BA vs. SC is indicated with a delta sign (Δ), HBA vs. SC is indicated with a pound sign 
(#), HBA vs. NC is indicated with a plus sign (+), and HBA vs. BA is indicated with a 
double dagger sign (‡).
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Fig. 6. 
Treatment effects on 9 skull distance measures. The y-axis indicates the mean length (± 
SEM) in mm. The ANOVA α level was adjusted to 0.0056 (=0.05/9) for the nine ANOVAs 
performed, followed by the Holm-Sidak method for pairwise comparisons (p < 0.05). 
Significant group differences are indicated within each panel. An asterisk (*) indicates 
significance between the following four pairs: BA vs. NC, HBA vs. NC, BA vs. SC, and 
HBA vs. SC. Significance between HBA vs. SC is indicated with a pound sign (#) and 
significance between HBA vs. BA is indicated with a double dagger sign (‡).
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Fig. 7. 
Treatment effects on 10 face distance measures. The y-axis indicates the mean length (± 
SEM) in mm. The ANOVA α level was adjusted to 0.005 (=0.05/10) for the ten ANOVAs 
performed, followed by the Holm-Sidak method for pairwise comparisons (p < 0.05). 
Significant group differences are indicated within each panel. An asterisk (*) indicates 
significance between the following four pairs: BA vs. NC, HBA vs. NC, BA vs. SC, and 
HBA vs. SC. Significance between BA vs. SC is indicated with a delta sign (Δ), HBA vs. 
SC is indicated with a pound sign (#), and HBA vs. NC is indicated with a plus sign (+).
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Table 1
Craniofacial measurements and landmarks.
Fig. Location Number Measurement
1 Skull 1 Upper facial deptha
2 Lower facial deptha
3 Cranial circumference
4 Orbital heighta
5 Orbital widtha
6 Minimal frontal width
7 Bitragal width
8 Bigonial width
9 Interorbital distance
10 Nasal length
2 Face 11 Nasal width
12 Nasal length
13 Nasal bridge length
14 Philtrum length
15 Lower facial height
16 Mid-facial deptha
17 Lower facial deptha
18 Palpebral fissure lengtha
19 Inner canthal width
20 Outer canthal width
Numbers are keyed to Figs. 1 and 2.
a
Both right and left side measurements were taken.
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